Streptococcal M1 protein-provoked cxc chemokine formation, neutrophil recruitment and lung damage are regulated by rho-kinase signaling

Journal of Innate Immunity

Volumn 4, Issue 4, 2012, Pages 399-408

  Zhang, Songen ^a   Rahman, Milladur ^a   Zhang, Su ^a   Herwald, Heiko ^a   Qi, Zhongquan ^a   Jeppsson, Bengt ^a   Thorlacius, Henrik ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Chemokines; Kinases; Leukocytes; Lung; Sepsis

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA CHEMOKINE; BACTERIAL PROTEIN; CD11B ANTIGEN; MESSENGER RNA; RHO KINASE; STREPTOCOCCAL M1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; LUNG INJURY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STREPTOCOCCUS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; CHEMOKINES, CXC; GENE EXPRESSION REGULATION; HUMANS; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; PULMONARY EDEMA; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84863309800     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000336182     Document Type: Article

References (40)

1. Cervera C, Almela M, Martinez-Martinez JA, Moreno A, Miro JM: Risk factors and management of Gram-positive bacteraemia. Int J Antimicrob Agents 2009; 34(SUPPL 4):S26-S30.
2. DiPiro JT: Pathophysiology and treatment of gram-negative sepsis. Am J Hosp Pharm 1990; 47(11 SUPPL 3):S6-S10.
3. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
4. Cunningham MW: Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470-511.
5. Collin M, Olsen A: Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 2000; 36: 1306-1318.
6. Pahlman LI, Malmstrom E, Morgelin M, Herwald H: M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes. Microbiology 2007; 153: 2458-2464.
7. Pahlman LI, Morgelin M, Eckert J, Johansson L, Russell W, Riesbeck K, et al: Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 2006; 177: 1221-1228.
8. Asaduzzaman M, Zhang S, Lavasani S, Wang Y, Thorlacius H: LFA-1 and MAC-1 mediate pulmonary recruitment of neutrophils and tissue damage in abdominal sepsis. Shock 2008; 30: 254-259.
9. Tilanus AM, de Geus HR, Rijnders BJ, Dwarkasing RS, van der Hoven B, Bakker J: Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature. Int J Infect Dis 2010; 14(SUPPL 3):e208-e212.
10. Vuilleumier H, Halkic N: Streptococcal toxic shock syndrome revealed by a peritonitis. Case report and review of the literature. Swiss Surg 2001; 7: 25-27.
11. Bacon KB, Oppenheim JJ: Chemokines in disease models and pathogenesis. Cytokine Growth Factor Rev 1998; 9: 167-173.
12. Li X, Klintman D, Liu Q, Sato T, Jeppsson B, Thorlacius H: Critical role of CXC chemokines in endotoxemic liver injury in mice. J Leukoc Biol 2004; 75: 443-452.
13. Schramm R, Schaefer T, Menger MD, Thorlacius H: Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J Leukoc Biol 2002; 72: 1122-1132.
14. Zhang S, Zhang S, Rahman M, Herwald H, Thorlacius H: Streptococcal M1 protein-induced lung injury is independent of platelets in mice. Shock 2010; 35: 86-91.
15. Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, et al: Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol 2002; 72: 571-579.
16. Barton GM: A calculated response: control of inflammation by the innate immune system. J Clin Invest 2008; 118: 413-420.
17. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S: An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999; 5: 221-225.
18. Slotta JE, Braun OO, Menger MD, Thorlacius H: Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo. Inflamm Res 2006; 55: 364-367.
19. Niggli V: Rho-kinase in human neutrophils: a role in signalling for myosin light chain phosphorylation and cell migration. FEBS Lett 1999; 445: 69-72.
20. Slotta JE, Laschke MW, Menger MD, Thorlacius H: Rho-kinase signalling mediates endotoxin hypersensitivity after partial hepatectomy. Br J Surg 2008; 95: 976-984.
21. Kitamura K, Tada S, Nakamoto N, Toda K, Horikawa H, Kurita S, et al: Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis. J Gastroenterol Hepatol 2007; 22: 2022-2033.
22. Laschke MW, Dold S, Jeppsson B, Schilling MK, Menger MD, Thorlacius H: Rho-kinase inhibitor attenuates cholestasis-induced CXC chemokine formation, leukocyte recruitment, and hepatocellular damage in the liver. J Surg Res 2010; 159: 666-673.
23. Santen S, Wang Y, Laschke MW, Menger MD, Jeppsson B, Thorlacius H: Rho-kinase signalling regulates CXC chemokine formation and leukocyte recruitment in colonic ischemia-reperfusion. Int J Colorectal Dis 2010; 25: 1063-1070.
24. Oka M, Fagan KA, Jones PL, McMurtry IF: Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension. Br J Pharmacol 2008; 155: 444-454.
25. Awla D, Hartman H, Abdulla A, Zhang S, Rahman M, Regner S, et al: Rho-kinase signalling regulates trypsinogen activation and tissue damage in severe acute pancreatitis. Br J Pharmacol 2011; 162: 648-658.
26. Kumar S, Boehm J, Lee JC: p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2: 717-726.
27. Kuldo JM, Ogawara KI, Werner N, Asgeirsdottir SA, Kamps JA, Kok RJ, et al: Molecular pathways of endothelial cell activation fortargeted) pharmacological intervention of chronic inflammatory diseases. Curr Vasc Pharmacol 2005; 3: 11-39.
28. Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA, et al: Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem 2002; 277: 14884-14893.
29. Zhang S, Rahman M, Zhang S, Wang Y, Herwald H, Jeppsson B, et al: p38 Mitogen-activated protein kinase signaling regulates streptococcal M1 protein-induced neutrophil activation and lung injury. J Leukoc Biol, 2012; 91: 137-145.
30. Asaduzzaman M, Rahman M, Jeppsson B, Thorlacius H: P-selectin glycoprotein-ligand- 1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis. Br J Pharmacol 2009; 156: 307-315.
31. Borzone G, Liberona L, Olmos P, Saez C, Meneses M, Reyes T, et al: Rat and hamster species differences in susceptibility to elastase- induced pulmonary emphysema relate to differences in elastase inhibitory capacity. Am J Physiol Regul Integr Comp Physiol 2007; 293:R1342-R1349.
32. Zhang X, Goncalves R, Mosser DM: The isolation and characterization of murine macrophages. Curr Protoc Immunol 2008; chapt 14:unit 14.1.
33. Zhang S, Rahman M, Zhang S, Qi Z, Herwald H, Thorlacius H: Simvastatin regulates CXC chemokine formation in streptococcal M1 protein-induced neutrophil infiltration in the lung. Am J Physiol Lung Cell Mol Physiol 2011; 300:L930-L939.
34. Pahlman LI, Olin AI, Darenberg J, Morgelin M, Kotb M, Herwald H, et al: Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol 2008; 10: 404-414.
35. Ropert C, Closel M, Chaves AC, Gazzinelli RT: Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase- 1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages. J Immunol 2003; 171: 1456-1465.
36. Gao X, Xu N, Sekosan M, Mehta D, Ma SY, Rahman A, et al: Differential role of CD18 integrins in mediating lung neutrophil sequestration and increased microvascular permeability induced by Escherichia coli in mice. J Immunol 2001; 167: 2895-2901.
37. Kamochi M, Kamochi F, Kim YB, Sawh S, Sanders JM, Sarembock I, et al: P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. Am J Physiol 1999; 277:L310-L319.
38. Herwald H, Cramer H, Morgelin M, Russell W, Sollenberg U, Norrby-Teglund A, et al: M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004; 116: 367-379.
39. Menezes GB, Lee WY, Zhou H, Waterhouse CC, Cara DC, Kubes P: Selective down-regulation of neutrophil Mac-1 in endotoxemic hepatic microcirculation via IL-10. J Immunol 2009; 183: 7557-7568.
40. Zhang XW, Liu Q, Wang Y, Thorlacius H: CXC chemokines, MIP-2 and KC, induce Pselectin- dependent neutrophil rolling and extravascular migration in vivo. Br J Pharmacol 2001; 133: 413-421.